Why the study?
How do different classes of beta-antagonists and their ancillary properties affect blood pressure in clinical and experimental hypertension?
Population
Patients with essential hypertension and experimental models
Design
Review
Authors
Loading...
Supports tailoring beta-blocker choice to ancillary properties in hypertension; leaves open need for head-to-head trials.
How do different classes of beta-antagonists and their ancillary properties affect blood pressure in clinical and experimental hypertension?
Ancillary properties of beta-antagonists, such as cardioselectivity and partial agonism, modify their haemodynamic profile and clinical utility in the management of hypertension.
J. D. Fitzgerald (1982) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: